new oral cancer drug in Canada called Sutent

You'll see a new oral cancer drug in Canada called Sutent.

Sutent (sunitinib) is for treating gastrointestinal stromal tumours (GIST) that have become resistant to Gleevec (imatinib).

It works similarly to Gleevec. Both drugs block proteins needed for the tumour's growth.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote